Learning Objectives:
1. Appreciate findings associated with CRS in COVID-19.
2. Understand the potential role of tocilizumab in COVID-19.
3. Recognize the data utilized to build study schema of the COVIDOSE clinical trial.
Session date:
05/12/2020 - 8:30am to 9:30am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Pankti Reid, M.D., MPH